Ken We Have it All? The Recent Surge in Illicit Peptide Therapy

From “mewing” to “bone-smashing”, and almost everything in between, the internet has quickly fallen into obsession with unconventional ways to enhance appearances. As multiple online communities emerge in the wake of this, one method seems to be among the most popular: injection of grey-market peptides. 

Although their spike in fame is recent, peptides have been around for a while. Insulin was first discovered in 1921, and others such as oxytocin and Ozempic have been FDA-approved since. 

Peptides are short chains of amino acids, which are the building blocks of proteins. They are produced naturally by the body and regulate a wide range of biological functions, such as hormone production, immune response, and cell signaling. Their small size enables them to be easily absorbed by the body, which makes artificial peptides particularly appealing because they can be altered to influence specific physiological processes. They are used in a wide variety of ways, including the treatment of hormonal imbalances, inflammation, anti-aging, athletic performance and recovery, weight management, and even skin tone.

What’s the catch? The problem with most of these wonder wellness drugs is that they have not yet been approved by the FDA. The approval process requires new substances to undergo rigorous testing to ensure that their benefits outweigh the risks, and without it, there is no way to ensure that unapproved drugs meet federal safety and efficacy standards. 

Fortunately for peptide producers, FDA approval does not equate to strict legality. While many trending peptides cannot be sold or marketed in the U.S. for their intended use, there are exceptions to the enforcement of their distribution that allow them to be sold under labels like “for research use only” or “not for human consumption”. This is where the grey market comes in: unregulated overseas sellers market their peptides online, often at a fraction of the price since they bypass expensive regulatory costs.

Designed by Freepik

The grey market is designed to dodge the traceability of unregulated peptide commerce, making it almost impossible to track their use. However, a 2026 study in the American Journal of Sports Medicine conducted a comprehensive scientific literature analysis that found the most popular samples to include BPC-157, CJC-1295 + Ipamorelin, GHK-Cu, and TB-500. 

Based on this study, Body Protection Compound-157, or BPC-157, “represents the most popular frontrunner of experimental peptides in regenerative medicine”. It is a growth hormone-stimulator isolated from human gastric juice that has shown promising effects in animal studies, including gastrointestinal healing, reduced inflammation, and improved tissue repair. Despite these alluring results, the safety is far from assured; human clinical evidence is grossly limited, and the small trial that does exist lacks a control and other key elements of a credible investigation. 

CJC-1295 + Ipamorelin are generally combined into a single peptide compound that increases growth hormone (GH) levels, making them attractive for stimulating muscle gain or fat loss. However, inaccurate dosage can push GH levels too high which can disturb metabolism and cause insulin resistance, posing a risk for diabetes. 

GHK-Cu is a copper-binding peptide that is secreted in human plasma after a tissue injury. It has been shown to have wound healing effects, antioxidant and anti-inflammatory effects, and is often promoted to improve skin and hair health. However, it works by stimulating angiogenesis (new blood‑vessel formation) to aid tissue repair. Since tumor growth also depends on angiogenesis, there is an unproven but scientifically plausible risk that GHK-Cu could promote tumor progression. Further studies are needed to assess this risk. 

Similarly, TB-500, known also as Thymosin Beta-4, has been shown to promote angiogenesis. It was originally sourced from the calf thymus and has revealed great potential in animal studies to promote many types of tissue repair and muscle growth. Although studies have found TB-500 to be a marker for highly metastatic cancer sites, meaning that it may have properties that promote tumors as well, contrasting research for this peptide shows potential for TB-500 to have tumor-suppressing effects in male breast cancer. As with many of these peptides, no studies have been found of TB-500 that involve human participants. 

A final peptide that has swept the internet is Melanotan II, popularized also as the “Barbie Drug”. It works as a synthetic analog to a hormone that induces skin hyperpigmentation, often motivated by “the pursuit of a tanned appearance” (Gilhooley et al., 2021). Clavicular, the controversial face of the booming online Looksmaxxing community, publicized his use of this peptide in a  2026 NYT interview, claiming that it allowed him to tan over “100 times quicker” to limit his UV exposure time. However, “increasing numbers of case reports indicate that the unregulated use of [melanotan II] is associated with [skin] complication[s]” (Habberma et al., 2017), including melanomas, or skin cancer.

Beyond the unknowns of these individual compounds, grey-market peptides introduce a new plethora of risks. Systematic screenings of falsified peptides found contamination, incorrect dosing, and even toxic impurities such as heavy metals in the samples. When combining these dangerous product inconsistencies with the underinvestigated compounds themselves, there is no way to fully know the effects of illicit peptides. 

Whether the growing popularity of these substances is due solely to recent scientific advances, or in part to deeper societal implications, this ‘sticky’ method of bodily altercation is now more accessible than ever. With the click of a button, grey-market peptides could arrive at any doorstep in days, packaged neatly and full of mystery; the price may be low, but the true worth remains just as mysterious. Although, as Clavicular may say, “Barbie has a great day every day, but Ken only has a great day if Barbie looks at him.”

By Taylor Zupan